Research articlePublished 29 Nov 2013
Development of a neuroprotective antioxidant by a â??mix-and-matchâ?� strategy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The compound 4-{[(4-hydroxyphenyl)amino]methyl}-2,6-di-tert-butylphenol (TRS1) was developed using a “mix-and-match” drug design approach for antioxidant-based neuroprotection and therapy. The commonly-used antipyretic drug, paracetamol, which is also found to act as a mild anti-inflammatory, was further modified by attaching a radical scavenger moiety to design a bifunctional bioactive molecule. Using a cell-free 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical reduction assay, and a 2',7'-dichlorofluorescein (DCFH) oxidation assay in cultured N2a mouse neuroblastoma and SH-SY5Y human neuroblastoma cells exposed to oxidative insult (serum deprivation), the radical scavenging ability of TRS1 was found to be comparable with other wellstudied antioxidants such as Trolox. The maintenance of antioxidant action of this compound in cells suggests this avenue and other multi-targeted drug discovery paradigms may
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalOxidants and Antioxidants in Medical Science
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Vijaya Kenche”
- BylineArticles whose byline prints “Carolin Tumpach1 Kevin J. Barnham”
- BylineArticles whose byline prints “Steven J. Collins”
- BylineArticles whose byline prints “Cathryn L. Haigh”
- BylineArticles whose byline prints “Simon C. Drew”
